|This Slide: #49 of 100|
Slide #49. Catamaran Corp. — RESTAT
Catamaran Corp. (CTRX)
Catamaran Corp. (NASDAQ: CTRX, TSX: CCT), a leading provider of pharmacy benefit management (PBM) services and technology, announced today the completion, effective as of October 1, 2013, of its previously disclosed acquisition of RESTAT, LLC ("RESTAT"), for a purchase price of $409.5 million in cash, subject to certain customary post-closing adjustments. The purchase price was funded from Catamaran's existing cash balance and $350 million in borrowings under its revolving credit facility.
Catamaran is a provider of pharmacy benefit management (PBM) services and healthcare information technology (HCIT) solutions to the healthcare benefit management industry. Co.'s PBM services are marketed under the Catamaran PBM brand and include electronic point-of-sale pharmacy claims management, retail pharmacy network management, mail pharmacy claims management, Medicare Part D services, benefit design consultation, and reporting and information analysis. Co.'s HCIT solutions include RxClaim® on-line transaction processing system, RxMax® rebate management system, RxTrack® data warehouse and analysis system, Zynchros suite of formulary management tools, and other software products.
Open the CTRX Page at The Online Investor »
Hold (2.39 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite